Praxis Precision Medicines, Inc. financial data

Symbol
PRAX on Nasdaq
Location
99 High Street, 30 Th Floor, Boston, MA
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Nov 5, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 738 % -35.9%
Debt-to-equity 11 % +27.5%
Return On Equity -66.9 % -21.9%
Return On Assets -60.3 % -19.4%
Operating Margin -3.93K % +61.6%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 25M shares +34.2%
Common Stock, Shares, Outstanding 21.2M shares +19%
Entity Public Float 733M USD +397%
Common Stock, Value, Issued 14K USD 0%
Weighted Average Number of Shares Outstanding, Basic 22M shares +16.4%
Weighted Average Number of Shares Outstanding, Diluted 22M shares +16.4%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 7.46M USD +365%
Research and Development Expense 246M USD +115%
General and Administrative Expense 54.7M USD +6.98%
Operating Income (Loss) -293M USD -78.7%
Nonoperating Income (Expense) 20.1M USD +54.5%
Net Income (Loss) Attributable to Parent -273M USD -80.8%
Earnings Per Share, Basic -12 USD/shares -140%
Earnings Per Share, Diluted -12 USD/shares -140%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 150M USD -11.3%
Cash, Cash Equivalents, and Short-term Investments 389M USD -5.35%
Assets, Current 274M USD -23.9%
Property, Plant and Equipment, Net 174K USD -37.2%
Operating Lease, Right-of-Use Asset 362K USD -73.7%
Other Assets, Noncurrent 0 USD -100%
Assets 396M USD -4.77%
Accounts Payable, Current 30.8M USD +105%
Accrued Liabilities, Current 21.6M USD +39.9%
Contract with Customer, Liability, Current 0 USD -100%
Liabilities, Current 52.9M USD +60.9%
Contract with Customer, Liability, Noncurrent 0 USD -100%
Operating Lease, Liability, Noncurrent 0 USD -100%
Liabilities 52.9M USD +57.4%
Accumulated Other Comprehensive Income (Loss), Net of Tax 500K USD -62.4%
Retained Earnings (Accumulated Deficit) -1.05B USD -35.1%
Stockholders' Equity Attributable to Parent 344M USD -10.2%
Liabilities and Equity 396M USD -4.77%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -53M USD -154%
Net Cash Provided by (Used in) Financing Activities 54.3M USD -70.3%
Net Cash Provided by (Used in) Investing Activities -51.1M USD +44%
Common Stock, Shares Authorized 150M shares 0%
Common Stock, Shares, Issued 21.2M shares +19%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -49.8M USD -170%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 150M USD -11.3%
Deferred Tax Assets, Valuation Allowance 218M USD +20.9%
Deferred Tax Assets, Gross 219M USD +20.7%
Operating Lease, Liability 1.37M USD -45.1%
Depreciation 47K USD -58%
Payments to Acquire Property, Plant, and Equipment 0 USD -100%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -274M USD -83%
Lessee, Operating Lease, Liability, to be Paid 1.43M USD -47.5%
Property, Plant and Equipment, Gross 1.59M USD 0%
Operating Lease, Liability, Current 436K USD -64.4%
Lessee, Operating Lease, Liability, to be Paid, Year Two 110K USD -91.7%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.32M USD +1.93%
Operating Lease, Weighted Average Discount Rate, Percent 0.09 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 62K USD -73.3%
Lessee, Operating Lease, Liability, to be Paid, Year Three 110K USD -91.7%
Deferred Tax Assets, Operating Loss Carryforwards 90.1M USD +20.9%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Additional Paid in Capital 1.39B USD +20.2%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 284K USD -49.2%
Share-based Payment Arrangement, Expense 32.6M USD -15.4%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%